Evidence map›Paper›PMID 31915074›Full record

ReviewStem cell research & therapy2020

Stem cell-derived cell sheet transplantation for heart tissue repair in myocardial infarction.

Rui Guo, Masatoshi Morimatsu, Tian Feng, Feng Lan, Dehua Chang, Feng Wan, Yunpeng Ling

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Stem cell research & therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rui GuoDepartment of Cardiac Surgery, Peking University Third Hospital, Beijing, 100191, China.
Masatoshi MorimatsuDepartment of Cardiovascular Physiology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences,, Okayama University, Okayama, 700-8558, Japan.
Tian FengDepartment of Cardiac Surgery, Peking University Third Hospital, Beijing, 100191, China. ftmasters6@163.com.
Feng LanDepartment of Cardiac Surgery, Peking University Third Hospital, Beijing, 100191, China. fenglan@ccmu.edu.cn.
Dehua ChangDepartment of Cardiac Surgery, Peking University Third Hospital, Beijing, 100191, China. dehua_chang@yahoo.com.
Feng WanDepartment of Cardiac Surgery, Peking University Third Hospital, Beijing, 100191, China. drfengwan@hotmail.com.
Yunpeng LingDepartment of Cardiac Surgery, Peking University Third Hospital, Beijing, 100191, China. micsling@pku.edu.cn.ORCID 0000-0003-3003-1724

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stem cell-derived sheet engineering has been developed as the next-generation treatment for myocardial infarction (MI) and offers attractive advantages in comparison with direct stem cell transplantation and scaffold tissue engineering. Furthermore, induced pluripotent stem cell-derived cell sheets have been indicated to possess higher potential for MI therapy than other stem cell-derived sheets because of their capacity to form vascularized networks for fabricating thickened human cardiac tissue and their long-term therapeutic effects after transplantation in MI. To date, stem cell sheet transplantation has exhibited a dramatic role in attenuating cardiac dysfunction and improving clinical manifestations of heart failure in MI. In this review, we retrospectively summarized the current applications and strategy of stem cell-derived cell sheet technology for heart tissue repair in MI.

Indexed as

AnimalsHumansMesenchymal Stem Cell TransplantationMyocardial InfarctionMyocardiumRatsSwineTissue EngineeringAngiogenesisCardiac tissueCell sheetCell therapyHeart failureInflammationMesenchymal stem cellsMyocardial infarctionPluripotent stem cellsSkeletal myoblasts

Identifiers

PMID31915074
PMCPMC6950817

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.